When.com Web Search

  1. Ads

    related to: fibromyalgia blood test markers for leukemia

Search results

  1. Results From The WOW.Com Content Network
  2. Tumor marker - Wikipedia

    en.wikipedia.org/wiki/Tumor_marker

    Tumor markers may be used for the following purposes: Monitoring the malignancy; When a malignant tumor is found by the presence of a tumor marker, the level of marker found in the body can be monitored to determine the state of the tumor and how it responds to treatment. If the quantity stays the same during treatment it can indicate that the ...

  3. Coagulation activation marker - Wikipedia

    en.wikipedia.org/wiki/Coagulation_activation_marker

    Coagulation activation markers are biomarkers of net activation of coagulation and fibrinolysis. [ 1 ] [ 2 ] Examples include prothrombin fragment 1+2 (F1+2), thrombin–antithrombin complex (TAT), fibrinopeptide A (FpA), fibrin monomers (FMs), plasmin-α 2 -antiplasmin complex (PAP), activated protein C–protein C inhibitor (APC-PCI), and D ...

  4. Cancer biomarker - Wikipedia

    en.wikipedia.org/wiki/Cancer_biomarker

    This tumor marker can be detected in the blood, saliva, or urine. [17] The possibility of identifying an effective biomarker for early cancer diagnosis has recently been questioned, in light of the high molecular heterogeneity of tumors observed by next-generation sequencing studies.

  5. Chronic lymphocytic leukemia - Wikipedia

    en.wikipedia.org/wiki/Chronic_lymphocytic_leukemia

    They share some of the same cell marker proteins, chromosome abnormalities, and gene mutations that are found in CLL. [37] [38] CLL-type MBL can be separated into two groups: Low-count MBL has monoclonal B-cell blood counts of <0.5x10 9 cells/liter (i.e. 0.5x10 9 /L) High-count MBL has blood monoclonal B-cell counts ≥0.5x10 9 /L but <5x10 9 ...

  6. Myeloproliferative neoplasm - Wikipedia

    en.wikipedia.org/wiki/Myeloproliferative_neoplasm

    The discovery of the association of MPNs with the JAK2 gene marker in 2005 and the CALR marker in 2013 improved the ability to classify MPNs. [19] MPNs were classified as blood cancers by the World Health Organization in 2008. [20] Previously, they were known as myeloproliferative diseases (MPD). In 2016, Mastocytosis was no longer classified ...

  7. Prognosis marker - Wikipedia

    en.wikipedia.org/wiki/Prognosis_marker

    A panel of epigenetic methylation marker has been explored for prognosis of ovarian cancer, and it is reported that the panel exhibited high specificity and sensitivity (both above 70%) as a screen marker. [5] Epigenetic markers have also shown promising potential as prognostic markers for bladder cancer. [6]